Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis
NCT01818544
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
94
Enrollment
INDUSTRY
Sponsor class
Conditions
Bronchiectasis
Interventions
DRUG:
BAY85-8501
DRUG:
Placebo
Sponsor
Bayer